Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Hunzelmann

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Clinical and Experimental Rheumatology|February 15, 2013
Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypesLenny van Bon, Jasper C A Broen, Mascha M V A P Schijvenaars, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2011
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseMarcus Maurer, Sabine Altrichter, Thomas Bieber, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Arthritis Research & Therapy|October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical featuresRudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
The Journal of Rheumatology|April 3, 2019
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ ComplicationPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
The Lancet. Rheumatology|May 3, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Fabian Müller, Andreas Wirsching, et al.
Arthritis Research & Therapy|November 24, 2022
Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registryNorbert Blank, Marc Schmalzing, Pia Moinzadeh, et al.
The Lancet. Rheumatology|August 15, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus - Authors' replyMelanie Hagen, Fabian Müller, Andreas Wirsching, et al.
Annals of the Rheumatic Diseases|June 7, 2021
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypesMarialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, et al.
Rheumatology (Oxford, England)|January 28, 2023
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic SclerosisMichael Kreuter, Francesco Bonella, Norbert Blank, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Clinical and Experimental Rheumatology|February 15, 2013
Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypesLenny van Bon, Jasper C A Broen, Mascha M V A P Schijvenaars, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2011
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidaseMarcus Maurer, Sabine Altrichter, Thomas Bieber, et al.
Annals of the Rheumatic Diseases|October 2, 2020
Genomic Risk Score impact on susceptibility to systemic sclerosisLara Bossini-Castillo, Gonzalo Villanueva-Martin, Martin Kerick, et al.
Arthritis Research & Therapy|October 25, 2011
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical featuresRudolf Mierau, Pia Moinzadeh, Gabriela Riemekasten, et al.
The Journal of Rheumatology|April 3, 2019
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ ComplicationPia Moinzadeh, Kathrin Kuhr, Elise Siegert, et al.
The Lancet. Rheumatology|May 3, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational studyMelanie Hagen, Fabian Müller, Andreas Wirsching, et al.
Arthritis Research & Therapy|November 24, 2022
Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registryNorbert Blank, Marc Schmalzing, Pia Moinzadeh, et al.
The Lancet. Rheumatology|August 15, 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with refractory systemic lupus erythematosus - Authors' replyMelanie Hagen, Fabian Müller, Andreas Wirsching, et al.
Annals of the Rheumatic Diseases|June 7, 2021
Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypesMarialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, et al.
Rheumatology (Oxford, England)|January 28, 2023
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic SclerosisMichael Kreuter, Francesco Bonella, Norbert Blank, et al.
Pageof 15